Actions

Emerging strategies and options: Difference between revisions

From MalariaETC

No edit summary
No edit summary
 
Line 2: Line 2:
----
----
'''Navigation'''</br>
'''Navigation'''</br>
<span style="font-size:90%"[[MalariaETC Index|Main Malaria Index]]''</span></br>
<span style="font-size:90%">[[MalariaETC Index|Main Malaria Index]]''</span></br>
<span style="font-size:90%">[[Rapid diagnostic tests (RDTs)|RDT main page]]''</span></br>
<span style="font-size:90%">[[Rapid diagnostic tests (RDTs)|RDT main page]]''</span></br>
<span style="font-size:90%">>[[RDT_test:_formats_of_tests|RDT Test Design]]''</span></br>
<span style="font-size:90%">>[[RDT_test:_formats_of_tests|RDT Test Design]]''</span></br>
<span style="font-size:90%">>>>Current page: '''New RDT Design strategies'''</span>
<span style="font-size:90%">>>Current page: '''New RDT Design strategies'''</span>
----
----



Latest revision as of 10:25, 30 September 2024


Navigation
Main Malaria Index
RDT main page
>RDT Test Design
>>Current page: New RDT Design strategies


Emerging Strategies for RDT design

Multiplexed detection strategies
These may be used in some circumstances to optimise performance according to local requirements:

(a) Where both P.falciparum and P.vivax are highly prevalent, then tests with specificity for each species may prove valuable - P.falciparum (HRP2) and P.vivax (Pv-pLDH) may be combined with or without a pan-specific antibody. This can offer some advantages in detecting dual infection by the two species.

(b) Where HRP2 deletion are frequent, they may cause a high risk for test failure, tests multiplexed to select for Pf-pLDH and HRP2 may improve detection in these circumstances.